| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 38 |
| 1 | METHOTREXATE | 33 |
| 2 | LEVETIRACETAM | 12 |
| 3 | LEVETIRACETAM IN SODIUM CHLORIDE | 12 |
| 4 | LEVETIRACETAM INJECTION | 12 |
| 5 | LEVETIRACETAM ORAL | 12 |
| 6 | MISOPROSTOL | 12 |
| 7 | TACROLIMUS | 10 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 10 |
| 9 | TACROLIMUS OINTMENT 0.1% | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MISOPROSTOL | 12 | 0.0012 |
| 1 | SIROLIMUS | 9 | 0.0007 |
| 2 | CEFACLOR | 1 | 0.0006 |
| 3 | METHYLDOPA | 3 | 0.0006 |
| 4 | OXCARBAZEPINE | 9 | 0.0006 |
| 5 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 1 | 0.0005 |
| 6 | ATAZANAVIR | 6 | 0.0004 |
| 7 | ZIDOVUDINE | 3 | 0.0003 |
| 8 | RISDIPLAM | 1 | 0.0002 |
| 9 | TEMOZOLOMIDE | 5 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostaglandin E1 Analog [EPC] | 12 | 0.0007 |
| 1 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 2 | Protease Inhibitor [EPC] | 7 | 0.0002 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 7 | 0.0001 |
| 4 | Purine Antimetabolite [EPC] | 10 | 0.0001 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 33 | 0.0001 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Anti-epileptic Agent [EPC] | 14 | 0.0001 |
| 9 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |